Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab 2020-01-07 08:25
Japanese Clinical Study of DiscGenics' Cell Therapy for Disc Degeneration Passes Initial Safety Review 2020-01-07 08:00
Presagen and Life Whisperer Announce Call-out for a Global IVF Clinic Collaboration at CES 2020 2020-01-06 23:47
Inovio Provides Update on Clinical Program Plans for 2020 2020-01-06 21:00
12th Consecutive Year Leading United States in Organ Donation for Gift of Life Donor Program 2020-01-06 20:00
BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma 2020-01-06 20:00
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer 2020-01-06 20:00
Lianluo Smart Announces Receipt of Nasdaq Non-compliance of Stockholders' Equity Notification 2020-01-06 19:00
Dr. Nalini Rajamannan Comments on FDA Congressional Letter to Senate Finance Committee After Kaiser Health News Reveals Access to Exempt FDA Database 2020-01-06 19:00
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs 2020-01-06 18:00
Abcam Announces Successful Acquisition of Expedeon's Proteomics and Immunology Business, Enhancing Its Conjugation Capability 2020-01-06 15:00
GPHL's international headquarters settle in Macao, first project during the fifth-term government of Macao SAR 2020-01-06 14:39
Nunaps raises US$4.2M to develop patient-centered digital therapeutics platform for brain damage 2020-01-06 12:54
Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment 2020-01-06 09:00
111 Inc to Attend the JP Morgan 2020 Healthcare Conference in San Francisco, January 14-15, 2020 2020-01-04 08:00
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency 2020-01-03 23:30
Huami Corporation CEO Issues Open Letter to Staff 2020-01-03 18:30
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility 2020-01-03 08:10
Fountain Medical Appoints Mr. Ling Zhen as the Co-Chairman and Chief Executive Officer 2020-01-02 09:30
WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392 2020-01-02 08:08
1 603 604 605 606 607 963